Vincristin-Teva
Vincristin-Teva is a generic from Teva Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 29.20 to CHF 38.30 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Teva Pharma AG
- ATC code
- L01CA02
- IT group
- 07.16.10 Cytostatica
- Active substances
- Vincristini sulfas
- Preparation type
- Generic
- On the SL since
- 15/03/1999
- Last price change
- 01/12/2020
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 1 mg/ml | Durchstf 1 ml | CHF 11.75 | CHF 29.20 | 15/03/1999 | A | 7680480001006 |
| Inj Lös 2 mg/2ml | Durchstf 2 ml | CHF 20.13 | CHF 38.30 | 15/03/1999 | A | 7680480001013 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
- die Behandlung akuter Leukämie;
- die Kombinationstherapie bei M. Hodgkin, Non-Hodgkin-Lymphom, inklusive Sonderformen, Rhabdomyosarkom, Neuroblastom, Wilms-Tumor, osteogenem Sarkom, Ewing-Sarkom, malignem Melanom, kleinzelligem Lungenkarzinom, gynäkologischen Tumoren des Kindesalters;
- die Behandlung idiopathischer thrombozytopenischer Purpura (Morbus Werlhof) bei Patienten, die auf eine Splenektomie und Kurzzeitbehandlung mit Corticosteroiden nicht angesprochen haben.
More preparations in this group
FAQ
Is Vincristin-Teva covered by Swiss health insurance?
Yes, but only under conditions. Vincristin-Teva is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Vincristin-Teva cost in Switzerland?
The public price is the maximum price set by the FOPH and for Vincristin-Teva ranges from CHF 29.20 to CHF 38.30 per pack. The ex-factory price ranges from CHF 11.75 to CHF 20.13. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages